PharMedium To Remediate And Operate Outsourcing Facilities Under FDA Consent Decree
Executive Summary
Outsourcer PharMedium has agreed to suspend sterile drug compounding at one of its facilities until it remedies GMP problems under the terms of a consent decree. A federal complaint said that the firm ignored a slew of microbiological and quality problems.